Jacques E Rossouw

Jacques E Rossouw

UNVERIFIED PROFILE

Are you Jacques E Rossouw?   Register this Author

Register author
Jacques E Rossouw

Jacques E Rossouw

Publications by authors named "Jacques E Rossouw"

Are you Jacques E Rossouw?   Register this Author

80Publications

3158Reads

35Profile Views

Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?

Lancet 2018 04 26;391(10131):1677. Epub 2018 Apr 26.

Fred Hutchinson Cancer Research Institute, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)30753-0DOI Listing
April 2018

Reply to DR Merkle.

Am J Clin Nutr 2018 02;107(2):297-298

MedStar Health Research Institute and Georgetown/Howard Universities Center for Clinical and Translational Research, Washington, DC (BVH).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/nqx040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248702PMC
February 2018

Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.

JAMA 2018 01;319(2):193-194

National Heart, Lung, and Blood Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2017.18316DOI Listing
January 2018

The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.

Menopause 2017 04;24(4):360-370

1Department of Epidemiology, University of Washington, Seattle, WA 2Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 3Division of Angiology and Haemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland 4Department of Medicine, University of Vermont, Burlington, VT 5Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL 6National Heart Lung and Blood Institute, Bethesda, MD 7Department of Preventive Medicine, University of California San Diego, San Diego, CA 8Department of Medicine, George Washington University, Washington, DC 9Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN 10Department of Biochemistry, Maastricht University, Maastricht, The Netherlands 11School of Nursing, University of Washington, Seattle, WA 12Department of Family Medicine and Public Health, University of California San Diego, San Diego, CA 13Department of Biostatistics, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000000777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365368PMC
April 2017

and Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function.

Authors:
Man Li Yong Li Olivia Weeks Vladan Mijatovic Alexander Teumer Jennifer E Huffman Gerard Tromp Christian Fuchsberger Mathias Gorski Leo-Pekka Lyytikäinen Teresa Nutile Sanaz Sedaghat Rossella Sorice Adrienne Tin Qiong Yang Tarunveer S Ahluwalia Dan E Arking Nathan A Bihlmeyer Carsten A Böger Robert J Carroll Daniel I Chasman Marilyn C Cornelis Abbas Dehghan Jessica D Faul Mary F Feitosa Giovanni Gambaro Paolo Gasparini Franco Giulianini Iris Heid Jinyan Huang Medea Imboden Anne U Jackson Janina Jeff Min A Jhun Ronit Katz Annette Kifley Tuomas O Kilpeläinen Ashish Kumar Markku Laakso Ruifang Li-Gao Kurt Lohman Yingchang Lu Reedik Mägi Giovanni Malerba Evelin Mihailov Karen L Mohlke Dennis O Mook-Kanamori Antonietta Robino Douglas Ruderfer Erika Salvi Ursula M Schick Christina-Alexandra Schulz Albert V Smith Jennifer A Smith Michela Traglia Laura M Yerges-Armstrong Wei Zhao Mark O Goodarzi Aldi T Kraja Chunyu Liu Jennifer Wessel Eric Boerwinkle Ingrid B Borecki Jette Bork-Jensen Erwin P Bottinger Daniele Braga Ivan Brandslund Jennifer A Brody Archie Campbell David J Carey Cramer Christensen Josef Coresh Errol Crook Gary C Curhan Daniele Cusi Ian H de Boer Aiko P J de Vries Joshua C Denny Olivier Devuyst Albert W Dreisbach Karlhans Endlich Tõnu Esko Oscar H Franco Tibor Fulop Glenn S Gerhard Charlotte Glümer Omri Gottesman Niels Grarup Vilmundur Gudnason Torben Hansen Tamara B Harris Caroline Hayward Lynne Hocking Albert Hofman Frank B Hu Lise Lotte N Husemoen Rebecca D Jackson Torben Jørgensen Marit E Jørgensen Mika Kähönen Sharon L R Kardia Wolfgang König Charles Kooperberg Jennifer Kriebel Lenore J Launer Torsten Lauritzen Terho Lehtimäki Daniel Levy Pamela Linksted Allan Linneberg Yongmei Liu Ruth J F Loos Antonio Lupo Christine Meisinger Olle Melander Andres Metspalu Paul Mitchell Matthias Nauck Peter Nürnberg Marju Orho-Melander Afshin Parsa Oluf Pedersen Annette Peters Ulrike Peters Ozren Polasek David Porteous Nicole M Probst-Hensch Bruce M Psaty Lu Qi Olli T Raitakari Alex P Reiner Rainer Rettig Paul M Ridker Fernando Rivadeneira Jacques E Rossouw Frank Schmidt David Siscovick Nicole Soranzo Konstantin Strauch Daniela Toniolo Stephen T Turner André G Uitterlinden Sheila Ulivi Dinesh Velayutham Uwe Völker Henry Völzke Melanie Waldenberger Jie Jin Wang David R Weir Daniel Witte Helena Kuivaniemi Caroline S Fox Nora Franceschini Wolfram Goessling Anna Köttgen Audrey Y Chu

J Am Soc Nephrol 2017 Mar 5;28(3):981-994. Epub 2016 Dec 5.

National Heart, Lung, and Blood Institute's Framingham Heart Study and the Center for Population Studies, Framingham, Massachusetts;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2016020131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328154PMC
March 2017

Theoretical Effects of Substituting Butter with Margarine on Risk of Cardiovascular Disease.

Epidemiology 2017 01;28(1):145-156

From the aDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI; bCenter for Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket, RI; cNational Heart, Lung, and Blood Institute, Bethesda, MD; dDepartment of Medicine, Brown University Alpert School of Medicine, Providence, RI; eUniversity of Tennessee Health Science Center, Memphis, TN; fDivision of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL; gBrigham and Women's Hospital, Harvard Medical School, Boston, MA; hDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; and iDepartment of Family Medicine, Brown University Alpert Medical School, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000557DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480968PMC
January 2017

Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Circulation 2017 01 9;135(1):7-16. Epub 2016 Nov 9.

From Department of Cardiology and Internal Medicine, Sint Antonius Hospital, Nieuwegein, The Netherlands (B.K.M., W.J.B., J.t.B.); Department of Haematology, University Medical Center Groningen, University of Groningen, The Netherlands (B.K.M., K. Meijer); Departments of Medicine and Pathology, University of Vermont, Burlington (M.C., N.A.Z.); Department of Hematology, Trondheim University Hospital, Norway (I.A.N., J.H.); Department of Family and Preventive Medicine, University of California San Diego, La Jolla (M.A.A.); K. G. Jebsen-Thrombosis Research and Expertise Center, Department of Clinical Medicine, University of Tromsø, Norway (S.K.B., J.- B.H.); Department of Clinical Epidemiology, Leiden University Medical Center, University of Leiden, The Netherlands (S.C.C.); Department of Internal Medicine, University Medical Center Groningen, University of Groningen, The Netherlands (R.T.G.); Department of Exercise and Health Sciences, University of Massachusetts, Boston (P.N.G.); Department of Epidemiology and Cardiovascular Health Research Unit, University of Washington, Seattle (S.H.); Laboratory for Molecular Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark (A.G.H.); Department of Clinical Cancer Prevention and Cardiology, University of Texas MD Anderson Cancer Center, Houston (S.G.L.); Division of Epidemiology and Community Health, University of Minnesota, Minneapolis (P.L.L., A.R.F.); Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.E.M.); Division of Cardiology, George Washington University School of Medicine and Health Sciences, Washington, DC (L.W.M.); Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K. Matsushita, Y.S.); Department of Public Health, Section for Epidemiology, Aarhus University, and Department of Cardiology, Aalborg University Hospital, Denmark (K.O.); Department of Cardiology, Bispebjerg Hospital, University of Copenhagen, Denmark (E.P.); Framingham Heart Study, Boston University School of Medicine, MA (M.P.); National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.R.); and Department of Hematology, Aalborg University Hospital, Denmark (M.T.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201424PMC
January 2017

Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.

Nat Genet 2016 10 12;48(10):1162-70. Epub 2016 Sep 12.

Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320952PMC
October 2016

Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study.

Am J Hypertens 2016 Feb 1;29(2):202-16. Epub 2015 Jul 1.

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpv081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723668PMC
February 2016

Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.

Arterioscler Thromb Vasc Biol 2016 Feb 17;36(2):418-24. Epub 2015 Dec 17.

From the Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN (K.C.J.); Fred Hutchinson Cancer Research Center, Seattle, WA (A.K.A., A.R.); Ohio State University Medical Center, Columbus, OH (R.J.); Oslo University Hospital and University of Oslo, Oslo, Norway (P.M.S., A.E.A.D.); Maastrich University, Maastrich, The Netherlands (J.R.); University of Leiden, Leiden, The Netherlands (F.R.); Brigham and Women's Hospital, Harvard University, Boston, MA (J.E.M.); George Washington University, Washington, DC (L.W.M.); Brown University, Providence, RI (S.L.); University of Pittsburgh, PA (L.H.K.); University of Vermont, Burlington, VT (M.C.); and National Heart, Lung, and Blood Institute, Bethesda, MD (J.E.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.115.306905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732914PMC
February 2016

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Nature 2015 Feb 10;518(7537):102-6. Epub 2014 Dec 10.

1] Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. [2] Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. [3] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114, USA. [4] Program in Medical and Population Genetics, Broad Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article

Download full-text PDF

Source
http://kooperberg.fhcrc.org/papers/2015do.pdf
Web Search
http://www.nature.com/doifinder/10.1038/nature13917
Publisher Site
http://dx.doi.org/10.1038/nature13917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319990PMC
February 2015

Reconciling the divergent findings from clinical trials and observational studies of menopausal hormone therapy for prevention of coronary heart disease.

Semin Reprod Med 2014 Nov 16;32(6):426-32. Epub 2014 Oct 16.

National Heart, Lung, and Blood Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1384625DOI Listing
November 2014

The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials.

J Hypertens 2014 Oct;32(10):2071-81; discussion 2081

aDepartment of Medicine, Columbia University Medical Center, New York, New York bDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts cDepartment of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo - SUNY, Buffalo, New York dDepartment of Family and Preventive Medicine, University of California San Diego, San Diego, California eDepartment of Epidemiology, Brown University, Providence, Rhode Island fDepartment of Medicine, North Florida/South Georgia Veterans Health System, University of Florida, Gainesville, Florida gDivision of Cardiology, George Washington University, Washington, District of Columbia hFred Hutchinson Cancer Research Center, Seattle, Washington iCenter for Family and Community Medicine, Columbia University Medical Center, New York, New York jNational Heart, Lung, and Blood Institute, Bethesda, Maryland kDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000000287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180281PMC
October 2014

Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk.

Genome Med 2012 13;4(7):57. Epub 2012 Jul 13.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580413PMC
May 2014

Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.

Genome Med 2013 27;5(12):112. Epub 2013 Dec 27.

Department of Clinical Cancer Prevention, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center, 6767 Bertner Street, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971342PMC
May 2014

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.

Menopause 2014 Mar;21(3):260-6

From the 1Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Los Angeles, CA; 2Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; 3National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; 4MedStar Health Research Institute, Hyattsville, MD; 5University of Florida College of Medicine-Jacksonville, Jacksonville, FL; 6Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN; 7George Washington University School of Medicine and Health Sciences, Washington, DC; 8Atlanta VA Medical Center, Decatur, GA; 9Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA; and 10Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0b013e31829a64f9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872264PMC
March 2014

Women's health initiative view of estrogen avoidance and all-cause mortality.

Am J Public Health 2013 Dec 17;103(12):e2. Epub 2013 Oct 17.

Ross L. Prentice, Garnet L. Anderson, and Andrea Z. LaCroix are with the Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA. JoAnn E. Manson is with the Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA. Sally A. Shumaker is with the Division of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC. Rowan T. Chlebowski is with the Division of Medicine Oncology/Hematology, Los Angeles Biomedical at Harbor, University of California Medical Center, Torrance. Barbara V. Howard is with the Medstar Research Institute, Hyattsville, MD. Marcia L. Stefanick is with the Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA. Rebecca D. Jackson is with the Ohio State University Medical Center, Columbus. Jean Wactawski-Wende is with the Department of Social and Preventive Medicine, University of Buffalo, The State University of New York, Buffalo. Jacques E. Rossouw is with the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2105/AJPH.2013.301604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828989PMC
December 2013

Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.

Curr Opin Lipidol 2013 Dec;24(6):493-9

aMedStar Health Research Institute, Hyattsville, Maryland bGeorgetown-Howard Universities Center for Clinical and Translational Science, Washington, District of Columbia cNational Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219554PMC
December 2013

Noakes misses the point.

S Afr Med J 2013 Dec;103(12):882

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7196/samj.7709DOI Listing
December 2013

Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

Obstet Gynecol 2013 Jan;121(1):172-6

National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/aog.0b013e31827a08c8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547645PMC
January 2013

Study had insufficient power to investigate safety.

BMJ 2012 Dec 3;345:e8146; author reply e8164. Epub 2012 Dec 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.e8146DOI Listing
December 2012

Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.

Genome Med 2012 Mar 12;4(3):19. Epub 2012 Mar 12.

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3-A410, POB 19024, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446269PMC
March 2012

Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.

Genome Med 2011 06 24;3(6):42. Epub 2011 Jun 24.

Fred Hutchinson Cancer Research Center, Divisions of Public Health Sciences, and Vaccine and Infectious Diseases, 1100 Fairview Avenue North, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218816PMC
June 2011

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Ann Intern Med 2010 Feb;152(4):211-7

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936769PMC
February 2010

Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer.

Cancer Epidemiol Biomarkers Prev 2010 Jan;19(1):74-9

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, PO Box 19024, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806599PMC
January 2010

Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

Arch Intern Med 2008 Nov;168(20):2245-53

Women's Health Initiative Branch, Division of Prevention and Population Sciences, National Heart, Lung, and Blood Institute, 6701 Rockledge Dr, Rockledge 2 Bldg, Ste 10018, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.168.20.2245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726792PMC
November 2008

Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.

Clin Trials 2007 ;4(3):207-17

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774507079252DOI Listing
December 2007

Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.

Menopause 2007 Jan-Feb;14(1):20-8

Department of Research, American College of Obstetricians and Gynecologists, Washington, DC 20024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.gme.0000229571.44505.cbDOI Listing
April 2007

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

JAMA 2007 Apr;297(13):1465-77

Women's Health Initiative Branch, National Heart, Lung, and Blood Institute, Bethesda, Md 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.297.13.1465DOI Listing
April 2007

Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.

Ann N Y Acad Sci 2006 Nov;1089:444-53

Women's Health Initiative, National Heart, Lung, and Blood Institute, Rockledge 2, Room 8106, 6701 Rockledge Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1196/annals.1386.046
Publisher Site
http://dx.doi.org/10.1196/annals.1386.046DOI Listing
November 2006

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Maturitas 2006 Sep 11;55(2):103-15. Epub 2006 Jul 11.

WHI Clinical Coordinating Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3-A410, P.O. Box 19024, Seattle, WA 98109-1024, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2006.05.004DOI Listing
September 2006

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.

Circulation 2006 May 15;113(20):2425-34. Epub 2006 May 15.

Department of Obstetrics and Gynecology, Wayne State University School of Medicine/Hutzel Women's Hospital, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.594077DOI Listing
May 2006

Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.

Thromb Haemost 2005 Jun;93(6):1108-16

Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0978, La Jolla, CA 92093-0978, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH04-09-0608DOI Listing
June 2005

Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.

Maturitas 2005 May;51(1):51-63

National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-7966, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2005.02.015DOI Listing
May 2005

Trials for menopausal women.

J Br Menopause Soc 2004 Dec;10 Suppl 2

National Heart, Lung and Blood Institute, Bethesda, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/1362180042721256DOI Listing
December 2004

The Women's Health Initiative recruitment methods and results.

Ann Epidemiol 2003 Oct;13(9 Suppl):S18-77

From the WHI Clinical Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1047-2797(03)00042-5DOI Listing
October 2003

Estrogen plus progestin and the risk of coronary heart disease.

N Engl J Med 2003 Aug;349(6):523-34

Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa030808DOI Listing
August 2003

The hormone therapy dilemma: women respond.

J Am Med Womens Assoc (1972) 2003 ;58(1):33-43

Applied Cancer Screening Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute in Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
February 2003

Hormones for coronary disease-full circle.

Lancet 2002 Dec 21-28;360(9350):1996-7

US Department of Health and Human Services, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(02)12030-7DOI Listing
January 2003

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

JAMA 2002 Aug;288(8):980-7

Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215-1204, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.288.8.980DOI Listing
August 2002

Effect of postmenopausal hormone therapy on cardiovascular risk.

J Hypertens Suppl 2002 May;20(2):S62-5

Women's Health Initiative, National Heart, Lung, and Blood Institute, 1 Rockledge Drive, Bethesda, MD 20892-7966, USA.

View Article

Download full-text PDF

Source
May 2002

Hormones, genetic factors, and gender differences in cardiovascular disease.

Cardiovasc Res 2002 Feb;53(3):550-7

Women's Health Initiative, National Heart, Lung and Blood Institute, 1 Rockledge Center, Suite 300, 6705 Rockledge Drive, Bethesda, MD 20892-7966, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0008-6363(01)00478-3DOI Listing
February 2002

Debate: The potential role of estrogen in the prevention of heart disease in women after menopause.

Curr Control Trials Cardiovasc Med 2000 ;1(3):135-138

National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC59619PMC
http://dx.doi.org/10.1186/cvm-1-3-135DOI Listing
January 2000